Healius Ltd

HLS: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|@gv!DJLOCK|^PLOCK|#YkH%??

Healius Earnings: Subdued Referrals Weigh on Result, but Margins Poised to Expand on Cost Savings

Healius' interim 2026 underlying EBIT improved to AUD 8 million versus an AUD 3 million loss last year. Revenue rose a solid 4% despite weak general practitioner referrals. Healius is guiding to roughly AUD 48 million in EBIT for the full year. Shares fell 7%.

Sponsor Center